Revvity Inc (RVTY)

Industry Diagnostics & Research

This stock can be held in an Investment ISA and an Investment Account

Sell

$85.89

Buy

$86.13

arrow-down$-0.62 (-0.72%)

Prices updated at 01 May 2026, 16:17 EDT

Prices minimum 15 mins delay

Prices in USD

PerkinElmer Inc is a diagnostics company that provides instruments, consumables, and services to biomedical, chemical and to general industrial markets. It operates in two segments namely Discovery and Analytical Solutions and Diagnostics.

S&P 500

0.6%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Diagnostics & Research

Chairman

Mr. Alexis P. Michas

CEO

Dr. Prahlad R. Singh, PhD

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

11,000

Head office

77 4th Avenue

Waltham

United States

02451

+1 781 663-6900

-

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Alexis P. Michas Non-Executive Chairman of the Board	0.18m
Mr. Joel S. Goldberg Senior Vice President, Administration, General Counsel and Secretary	0.56m
Dr. Peter Barrett,PhD Independent Director	0.11m
Mr. Tajinder S. Vohra Senior Vice President, Global Operations	0.49m
Dr. Sophie V. Vandebroek, PhD Independent Director	0.09m
Dr. Frank R. Witney,, PhD Independent Director	0.09m
Ms. Pascale Witz, M. Sc.,M.B.A. Independent Director	0.09m
Mr. Michel Pericles Vounatsos Independent Director	0.11m
Dr. Prahlad R. Singh, PhD Director, President and Chief Executive Officer	1.13m
Mr. Samuel R. Chapin Independent Director	0.12m
Ms. Miriame Victor Senior Vice President and Chief Commercial Officer	0.50m
Mr. Michael A Klobuchar Independent Director	0.09m
Dr. Michelle McMurry-Heath, M.D.,PhD Independent Director	0.09m
Mr. Maxwell Krakowiak Senior Vice President and Chief Financial Officer	0.55m
Ms. Anita Gonzales Vice President and Chief Accounting Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
T. Rowe Price Investment Management,Inc.	38,292,097
T. Rowe Price Capital Appreciation Fund	14,151,754
Vanguard Group Inc	13,160,897
Janus Capital Management LLC	11,553,380
T. Rowe Price	8,666,373

Director dealings

Date chevron-l-regular chevron-r-regular	Action
15 Dec 2025	-
29 Oct 2025	-
29 Oct 2025	-
15 Sep 2025	-
15 Sep 2025	-
27 Aug 2025	-
15 Aug 2025	-
15 Aug 2025	-
15 Aug 2025	-
15 Aug 2025	-
16 Jun 2025	-
29 May 2025	-
30 Apr 2025	-
30 Apr 2025	-
30 Apr 2025	-
30 Apr 2025	-
30 Apr 2025	-
30 Apr 2025	-
30 Apr 2025	-
30 Apr 2025	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.